You are here

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Obu-shi,Morioka-machi, Aichi, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Partial Epilepsies
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
3-15 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Japanese male or females, ages 3-15 years old at acquisition of informed consent, 15
years old or less at the baseline visit

- Seizures are classified as simple partial, complex partial or partial becoming
secondarily generalized (defined according to the International League Against
Epilepsy)

- Have not been able to achieve adequate seizure control with antiepileptic drugs

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Seizures related to drugs or acute medical illness

- History of any serious medical or psychiatric disorder

- Diagnosis or history of a structural CNS lesion or an encephalopathy shown to be
progressive

NCT00603473
Pfizer
Completed
A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Partial Epilepsies
NCT00351611
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now